AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
FARICIMAB
4 registrations across 4 African markets— 4 active
Markets with FARICIMAB
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| VABYSMO 6MG/ 0,05 ML SOLUTION INJECTABLE BOITE DE 1 | 🇨🇮Côte d'Ivoire | F. HOFFMANN-LA ROCHE LTD | active | Jan 2029 |
| VABYSMO | 🇿🇦South Africa | Roche Products (Pty) Ltd | active | Nov 2028 |
| Vabysmo** Solution for injection | 🇳🇬Nigeria | Roche Products Limited | active | Jul 2028 |
| Vabysmo 6 mg/0.05 mL solution for injection Solution for injection | 🇹🇿Tanzania | F.Hoffmann-La Roche Limited | active | — |
FARICIMAB in Africa — Regulatory Overview
FARICIMAB is registered across 4 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, Nigeria, Tanzania, South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 4 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.